US2006093655A1PendingUtilityA1

Method for making a reinforced absorbable multilayered hemostatic wound dressing

Assignee: BAR LILLIANPriority: Oct 20, 2004Filed: Oct 17, 2005Published: May 4, 2006
Est. expiryOct 20, 2024(expired)· nominal 20-yr term from priority
A61L 15/64B32B 2262/0276A61L 15/26A61L 15/28B32B 2262/062B32B 2262/06B32B 2250/20B32B 27/36B32B 5/022B32B 5/024B32B 2556/00B32B 23/10B32B 5/26Y10T442/2525A61L 2300/608A61L 2300/418B32B 5/026B32B 2262/04B32B 23/02A61L 15/32A61L 2400/04B32B 2307/726A61L 15/44A61L 15/42A61F 13/01029
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention is directed to a method of making a reinforced absorbable multilayered hemostatic wound dressing comprising a first absorbable nonwoven fabric, a second absorbable woven or knitted fabric, thrombin and fibrinogen.

Claims

exact text as granted — not AI-modified
1 . A method for making a multilayered wound dressing having a first absorbable nonwoven fabric, a second absorbable woven or knitted fabric, thrombin and fibrinogen, comprising the steps of: 
 (a) crimping absorbable polymer fibers or yarns in the range of about 10 to 30 crimps per inch;    (b) cutting the crimped fibers or yarns to a staple length between about 0.1 and 2.5 inch;    (c) carding the staple to form the first absorbable nonwoven fabric while controlling the humidity to about 40 to 60%, at a room temperature of about 60 to 75° C.;    (d) attaching the first absorbable nonwoven fabric to the second absorbable woven or knitted fabric;    (e) applying thrombin and fibrinogen to the first absorbable nonwoven fabric.    
   
   
       2 . The method of  claim 1 , where the first absorbable nonwoven fabric comprises fibers comprised of aliphatic polyester polymers or copolymers of one or more monomers selected from the group consisting of lactic acid, lactide (including L-, D-, meso and D, L mixtures), glycolic acid, glycolide, δ-caprolactone, p-dioxanone, and trimethylene carbonate.  
   
   
       3 . The method of  claim 2 , where the first absorbable nonwoven fabric comprises glycolide/lactide copolymer.  
   
   
       4 . The method of  claim 2 , where the second absorbable woven or knitted fabric comprises oxidized polysaccharides.  
   
   
       5 . The method of  claim 4 , where the second absorbable woven or knitted fabric comprises oxidized cellulose.  
   
   
       6 . The method of  claim 5 , where the second absorbable woven or knitted fabric comprises oxidized regenerated cellulose.  
   
   
       7 . The method of  claim 5 , where the second absorbable woven or knitted fabric is an absorbable knitted fabric comprising oxidized regenerated cellulose.  
   
   
       8 . The method of  claim 1 , where the first absorbable nonwoven fabric comprises glycolide/lactide copolymer, and the second absorbable woven or knitted fabric comprises oxidized regenerated cellulose.  
   
   
       9 . The method of  claim 8 , where the first absorbable nonwoven fabric comprises staple having a length from about 0.75 to 1.5 inches.  
   
   
       10 . The method of  claim 8 , where the first absorbable nonwoven fabric comprises staple having a length from about 1.0 to 1.3 inches.  
   
   
       11 . The method of  claim 8 , where the first absorbable nonwoven fabric comprises a copolymer of glycolide and lactide, in an amount ranging from about 70 to 95% by molar basis of glycolide and the remainder lactide, and the second absorbable woven or knitted fabric comprises oxidized regenerated cellulose.  
   
   
       12 . The method of  claim 11 , where the staple is derived from fiber of about 1 to 4 denier per filament.  
   
   
       13 . The method of  claim 8 , where the first absorbable nonwoven fabric has a basis weight of about 0.01 to 0.2 g/in 2 ; the second absorbable woven or knitted fabric has a basis weight of about 0.001 to 0.2 g/in 2 ; and the multilayered dressing having the thrombin and fibrinogen thereon has a basis weight of about 0.1 and 1.0 g/in 2 .  
   
   
       14 . The method of  claim 8 , wherein the thrombin activity on the multilayered dressing ranges from about 20 to 500 IU/cm 2 , and the fibrinogen activity on the multilayered dressing ranges from about 2 to 15 mg/cm 2 .

Join the waitlist — get patent alerts

Track US2006093655A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.